Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma
Author:
Affiliation:
1. University of Alberta and Cross Cancer Institute; Department of Oncology; Edmonton Alberta Canada T6G 1Z2
2. Faculty of Medicine, Ain Shams University; Clinical Oncology; Cairo Egypt 11661
Publisher
Wiley
Subject
Pharmacology (medical)
Link
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011313.pub3/epdf/full
Reference93 articles.
1. SIRveNIB: selective internal radiation therapy versus sorafenib in Asia-Pacific patients with hepatocellular carcinoma;Chow;Journal of Clinical Oncology,2018
2. Kolligs F Bilbao J Jakobs T Iñarrairaegui M Nagel J Rodriguez M Pilot randomized trial of selective internal radiation therapy vs. chemoembolization in unresectable hepatocellular carcinoma Liver International 2015 1715 21
3. Randomized comparison of selective internal radiotherapy (SIRT) versus drug-eluting bead transarterial chemoembolization (DEB-TACE) for the treatment of hepatocellular carcinoma;Pitton;Cardiovascular and Interventional Radiology,2015
4. Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma;Ricke;Journal of Hepatology,2019
5. Y90 radioembolization significantly prolongs time to progression compared with chemoembolization in patients with hepatocellular carcinoma;Salem;Gastroenterology,2016
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Applications of Yttrium-90 (90Y) in Hepatocellular Carcinoma;OncoTargets and Therapy;2024-02
2. S3-Leitlinie „Diagnostik und Therapie biliärer Karzinome“ – Kurzversion;Zeitschrift für Gastroenterologie;2024-02
3. S3-Leitlinie „Diagnostik und Therapie biliärer Karzinome“ – Langversion 4.0;Zeitschrift für Gastroenterologie;2024-02
4. S3-Leitlinie „Diagnostik und Therapie des Hepatozellulären Karzinoms“ – Kurzversion;Zeitschrift für Gastroenterologie;2024-01
5. S3-Leitlinie „Diagnostik und Therapie des Hepatozellulären Karzinoms“ – Langversion 4.0;Zeitschrift für Gastroenterologie;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3